News Daily News More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions L.A. McKeown October 26, 2015
News Industry News One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015 October 20, 2015
News Industry News STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1) October 12, 2015
News Conference News TCT 2015 Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis October 12, 2015
News Industry News Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants October 12, 2015
News Industry News Follow-up imaging data from APPOSITION IV study to be presented at TCT conference in San Francisco October 12, 2015
News Conference News TCT 2015 Absorb BVS Matches Xience V in Chinese Patients Todd Neale October 12, 2015
News Conference News TCT 2015 Novel Devices Present New Treatment Options for STEMI Yael L. Maxwell October 11, 2015
News Daily News OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent Yael L. Maxwell September 14, 2015
News Conference News ESC 2015 ABSORB Trials Pit BRS Against Second-Generation DES Caitlin E. Cox September 02, 2015
News Daily News Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year L.A. McKeown August 10, 2015
News Daily News Study Sheds Light on Use of Stress Testing Post-PCI in VA System L.A. McKeown July 22, 2015
News Industry News U.S. to vie with India for top bioabsorbable stent market after FDA approval June 25, 2015
News Daily News In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries June 16, 2015
News Daily News Endurant Stent Graft Appears Safe, Effective in AAA Patients With Challenging Anatomy May 28, 2015
News Conference News EuroPCR 2015 Studies Provide Encouraging Results for DCB in Long SFA Lesions Caitlin E. Cox May 22, 2015
News Industry News Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions May 20, 2015
News Industry News EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment May 19, 2015